Paul Tudor Jones’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Paul Tudor Jones’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-412,077	Closed	-$10.8M	–	1470
2019 Q1	$10.8M	Buy	+412,077	New	+$7.7M	0.44%	27
2017 Q4	–	Sell	-24,000	Closed	-$405K	–	1390
2017 Q3	$405K	Buy	+24,000	New	+$392K	0.01%	720

Paul Tudor Jones's CMTA Position: Q2 2019 in Review

Paul Tudor Jones sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 412,077 shares — an estimated $10.8M sold.

Paul Tudor Jones first reported a position in CMTA in Q3 2017 and held it in 2 quarters. The position peaked at $10.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Paul Tudor Jones reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Paul Tudor Jones sold 412,077 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $10.8M.
Paul Tudor Jones first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 2 quarters.
Paul Tudor Jones's Clementia Pharmaceuticals Inc. position peaked at $10.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Tudor Investment Corp's 13F filing for Q2 2019, filed 14 Aug 2019.